Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection.

Clausen LN, Weis N, Ladelund S, Madsen L, Lunding S, Tarp B, Christensen PB, Krarup HB, Møller A, Gerstoft J, Clausen MR, Benfield T; DANHEP group.

Int J Mol Sci. 2015 Feb 2;16(2):3213-25. doi: 10.3390/ijms16023213.

2.

Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients.

Salado-Rasmussen K, Knudsen A, Krarup HB, Katzenstein TL, Gerstoft J.

Scand J Infect Dis. 2014 Sep;46(9):617-23. doi: 10.3109/00365548.2014.920102. Epub 2014 Jun 16.

PMID:
24934985
3.

Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Serre SB, Krarup HB, Bukh J, Gottwein JM.

J Virol. 2013 Dec;87(23):12776-93. doi: 10.1128/JVI.00901-13. Epub 2013 Sep 18.

4.

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.

Christensen PB, Hay G, Jepsen P, Omland LH, Just SA, Krarup HB, Weis N, Obel N, Cowan S.

BMC Infect Dis. 2012 Aug 6;12:178.

5.

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C.

Christensen PB, Krarup HB, Laursen AL, Madsen PH, Pedersen C, Schlichting P, Orholm M, Ring-Larsen H, Bukh J, Krogsgaard K.

Scand J Gastroenterol. 2012 Sep;47(8-9):1115-9. doi: 10.3109/00365521.2012.694905. Epub 2012 Jun 7.

PMID:
22670704
6.

MSH6 mutations are frequent in hereditary nonpolyposis colorectal cancer families with normal pMSH6 expression as detected by immunohistochemistry.

Okkels H, Lindorff-Larsen K, Thorlasius-Ussing O, Vyberg M, Lindebjerg J, Sunde L, Bernstein I, Klarskov L, Holck S, Krarup HB.

Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):470-7. doi: 10.1097/PAI.0b013e318249739b.

PMID:
22495361
7.

High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol.

Pedersen IS, Krarup HB, Thorlacius-Ussing O, Madsen PH.

BMC Mol Biol. 2012 Mar 26;13:12. doi: 10.1186/1471-2199-13-12.

8.

Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland.

Rex KF, Krarup HB, Laurberg P, Andersen S.

Scand J Gastroenterol. 2012 Jun;47(6):692-701. doi: 10.3109/00365521.2011.634026. Epub 2012 Jan 10.

PMID:
22229496
9.

Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.

Harder KM, Cowan S, Eriksen MB, Krarup HB, Christensen PB.

Vaccine. 2011 Nov 21;29(50):9303-7. doi: 10.1016/j.vaccine.2011.10.028. Epub 2011 Oct 19.

PMID:
22019756
10.

Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.

Andersen V, Ernst A, Sventoraityte J, Kupcinskas L, Jacobsen BA, Krarup HB, Vogel U, Jonaitis L, Denapiene G, Kiudelis G, Balschun T, Franke A.

BMC Med Genet. 2011 Oct 13;12:139. doi: 10.1186/1471-2350-12-139.

11.

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.

Hansen N, Obel N, Christensen PB, Kjær M, Laursen AL, Krarup HB, Møller A, Schlichting P, Bukh J, Weis N; Danish Database for Hepatitis B and C (DANHEP)- group.

BMC Infect Dis. 2011 Jun 21;11:177. doi: 10.1186/1471-2334-11-177.

12.

Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.

Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U.

World J Gastroenterol. 2011 Jan 14;17(2):197-206. doi: 10.3748/wjg.v17.i2.197.

13.

Common polymorphisms in the microsomal epoxide hydrolase and N-acetyltransferase 2 genes in association with inflammatory bowel disease in the Danish population.

Ernst A, Andersen V, Ostergaard M, Jacobsen BA, Pedersen IS, Drewes AM, Okkels H, Krarup HB.

Eur J Gastroenterol Hepatol. 2011 Mar;23(3):269-74. doi: 10.1097/MEG.0b013e3283438a44.

PMID:
21228703
14.

Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.

Andersen V, Nimmo E, Krarup HB, Drummond H, Christensen J, Ho GT, Ostergaard M, Ernst A, Lees C, Jacobsen BA, Satsangi J, Vogel U.

Inflamm Bowel Dis. 2011 Apr;17(4):937-46. doi: 10.1002/ibd.21440. Epub 2010 Aug 27.

PMID:
20803508
15.

The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.

Andersen V, Ernst A, Christensen J, Østergaard M, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U.

BMC Med Genet. 2010 May 28;11:82. doi: 10.1186/1471-2350-11-82.

16.

Genetic variants of glutathione S-transferases mu, theta, and pi display no susceptibility to inflammatory bowel disease in the Danish population.

Ernst A, Andersen V, Østergaard M, Jacobsen BA, Dagiliene E, Pedersen IS, Drewes AM, Okkels H, Krarup HB.

Scand J Gastroenterol. 2010 Sep;45(9):1068-75. doi: 10.3109/00365521.2010.490594.

PMID:
20459366
17.

Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population.

Østergaard M, Ernst A, Labouriau R, Dagiliené E, Krarup HB, Christensen M, Thorsgaard N, Jacobsen BA, Tage-Jensen U, Overvad K, Autrup H, Andersen V.

Scand J Gastroenterol. 2009;44(1):65-73. doi: 10.1080/00365520802400826.

PMID:
18819034
18.

Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population.

Nilbert M, Wikman FP, Hansen TV, Krarup HB, Orntoft TF, Nielsen FC, Sunde L, Gerdes AM, Cruger D, Timshel S, Bisgaard ML, Bernstein I, Okkels H.

Fam Cancer. 2009;8(1):75-83. doi: 10.1007/s10689-008-9199-3. Epub 2008 Jun 20.

PMID:
18566915
19.

Entecavir therapy induces de novo HIV reverse-transcriptase M184V mutation in an antiretroviral therapy-naive patient.

Jakobsen MR, Arildsen H, Krarup HB, Tolstrup M, Østergaard L, Laursen AL.

Clin Infect Dis. 2008 May 1;46(9):e88-91. doi: 10.1086/587174.

20.

Benign course of long-standing hepatitis B virus infection among Greenland Inuit?

Krarup HB, Andersen S, Madsen PH, Okkels H, Hvingel BH, Laurberg P.

Scand J Gastroenterol. 2008 Mar;43(3):334-43. doi: 10.1080/00365520701712198.

PMID:
18266176
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk